that s a really good question. i think this immunisation programme is unprecedented and so is the vaccine s safety monitoring programme that goes with that. so we have delivered over 8 billion doses according to a recent estimate of this vaccine so far and we have had vaccine so far and we have had vaccine safety systems, surveillance systems that have been upgraded to match the magnitude of this programme. so i think, the safety is being monitored and obviously, these signals, any signals are taken seriously, but what i would be reassured that this is not a novel vaccine any more. we have experience with the previous adverse events data, but also we know what to look for, where to look for in terms of risk groups et cetera.- to look for in terms of risk groups et cetera. 0k, professor saad omer. groups et cetera. 0k, professor saad omer, we groups et cetera. 0k, professor saad omer, we will groups et cetera. 0k, professor saad omer, we will have - groups et cetera. 0k, professor